top of page
The novel tetrahydrofuran derivative ANAVEX2-73 attenuated GSK-3β activation and Tau hyperphosphorylation in a nontransgenic Alzheimer’s disease model in mice.
![Anavex-1-1666x833.png](https://static.wixstatic.com/media/432182_ced8c5c5e2ce4a2db775b0ec5f5b850e~mv2.jpg/v1/fill/w_883,h_423,al_c,q_85,usm_0.66_1.00_0.01,enc_auto/Anavex-1-1666x833.jpg)
Alzheimer’s Association International Conference, July 16-21, 2011, Paris, France
Valentine Lahmy, Susanna Malmstrom, Johann Meunier, Vanessa Villard, Alexandre Vamvakides and Tangui Maurice
1/0
bottom of page